Blue Water Life Science Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$12.6M |
| 2 |
Guardant Health
GH
|
+$6.71M |
| 3 |
CareDx
CDNA
|
+$4.97M |
| 4 |
Natera
NTRA
|
+$4.83M |
| 5 |
Agilent Technologies
A
|
+$2.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Twist Bioscience
TWST
|
+$10.3M |
| 2 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
+$6.81M |
| 3 |
CELL
PhenomeX Inc. Common Stock
CELL
|
+$2.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.85% |
| 2 | Materials | 19.52% |
| 3 | Technology | 1.04% |
| 4 | Financials | 0.45% |
| 5 | Communication Services | 0.31% |
Similar funds
Blue Water Life Science Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, Blue Water Life Science Advisors held 26 positions worth $205M, up 20% from $170M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Blue Water Life Science Advisors deployed $18.6M of net new capital in Q1 2021, opening 5 new positions and adding to 6 existing holdings. Its largest new stake was Agilent Technologies: 20,938 shares worth $2.66M.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 90% a quarter earlier, followed by Materials and Technology.
On the sell side, the largest reduction was PhenomeX Inc. Common Stock, an estimated $2.28M trimmed.
- Blue Water Life Science Advisors's largest Q1 2021 buy was Agilent Technologies: 20,938 shares worth $2.66M.
- Blue Water Life Science Advisors added most to Exact Sciences in Q1 2021, an estimated $12.6M increase.
- Blue Water Life Science Advisors's biggest Q1 2021 reduction was PhenomeX Inc. Common Stock, cutting an estimated $2.28M.
- Blue Water Life Science Advisors fully exited Twist Bioscience in Q1 2021, selling an estimated $10.3M.
- Blue Water Life Science Advisors's ten largest holdings make up 97% of its $205M portfolio in Q1 2021.
- Blue Water Life Science Advisors opened 5 new positions and closed 2 in Q1 2021.
- Blue Water Life Science Advisors's portfolio value rose 20% quarter-over-quarter to $205M.
Based on Blue Water Life Science Advisors's 13F filing for Q1 2021, filed 14 May 2021.